23 Dec 2022 07:00
Â
Yourgene Health plcÂ
("Yourgene" or the "Company")
Â
 Posting of Circular and Notice of General Meeting
Â
The Board of Yourgene Health plc (AIM: YGEN), is pleased to confirm that, further to the announcements made on 21 December 2022 and 22 December 2022, regarding the proposed Capital Raising, a circular (the "Circular"), including the Notice of General Meeting and a Form of Proxy was posted yesterday to shareholders.
Â
The General Meeting will be held at Skelton House, Lloyd Street North, Manchester Science Park, Manchester M15 6SH on 9 January 2023 at 4.00 p.m.
Â
A copy of the Circular will shortly be available to download from the Company's website at http://www.yourgene-health.com/investors/key-documents/shareholder-communications.
Â
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular.
Â
The expected timetable relating to the Capital Raising is set out below.
 | 2022 |
Announcement of the Capital Raising  | 21 December |
Announcement of Retail Offer  | 22 December |
Publication and posting of the Circular and Form of Proxy  | 22 December |
First Admission and commencement of dealings in the First Admission Shares  | 8.00 a.m. on 23 December |
CREST stock accounts expected to be credited for the First Admission Shares (where applicable) Â | 23 December |
Launch of Retail Offer  | 23 December |
2023 | |
Posting of share certificates for the First Admission Shares by the Registrar (where applicable) Â | by no later than 5 January |
Latest time and date for receipt of Forms of Proxy and CREST voting instructions  | 5.00 p.m. on 5 January |
Close of Retail Offer  | 6 January |
General Meeting  | 4.00 p.m. on 9 January |
Results of the General Meeting announced through a Regulatory Information Service  |  9 January |
Second Admission and commencement of dealings in the Second Admission Shares and the Retail Shares  | 8.00 a.m. on 11 January |
Where applicable, expected date for CREST accounts to be credited in respect of Second Admission Shares in uncertificated form  | 11 January |
Posting of share certificates for the Second Admission Shares by the Registrar (where applicable) Â | by no later than 24 January |
Long Stop Date  |  30 January |
Â
Each of the times and dates above refer to London time and are subject to change. Any such change will be notified to Shareholders by an announcement through a Regulatory Information Service. All events listed in the above timetable following the General Meeting are conditional on the passing of the Resolutions at the General Meeting.
Â
Enquiries:
Â
Yourgene Health plc Lyn Rees, Chief Executive Officer | Tel: +44 (0)161 669 8122 investors@yourgene-health.com |
Barry Hextall, Chief Financial Officer | |
Joanne Cross, Director of Marketing | |
 | |
Cairn Financial Advisers LLP (NOMAD) | Tel: +44 (0)20 7213 0880 |
Liam Murray / James Caithie / Ludovico Lazzaretti | |
 | |
Singer Capital Markets (Corporate Broker) | Tel: +44 (0)20 7496 3000 |
Aubrey Powell / Tom Salvesen / George Tzimas | |
 | |
Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or Yourgene@walbrookpr.com |
Paul McManus / Lianne Applegarth / Alice Woodings | Mob: 07980 541 893 / 07584 391 303 / 07407 804 654 |
Â